Journal ArticleOPEN ACCESS

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

  • Martín M
  • Custodio S
  • Casas M
  • et al.
The Oncologist (2013) 18(8) 917-923
DOI: 10.1634/theoncologist.2012-0479
38Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Explain the prognostic value of baseline CTCs. Describe the predictive value of CTCs at day 21 after chemotherapy. Explain the meaning of the change of CTCs from baseline to day 21 after chemotherapy.

Cite

CITATION STYLE

APA

Martín, M., Custodio, S., Casas, M.-L. M., García-Sáenz, J.-Á., Torre, J.-C., Bellón-Cano, J.-M., … Díaz-Rubio, E. (2013). Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer. The Oncologist, 18(8), 917–923. https://doi.org/10.1634/theoncologist.2012-0479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free